CAM
BMY icon

CMT Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

CMT Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-247,000
Closed -$15.7M – 27
2017
Q3 		$15.7M Buy
247,000
+98,100
+66% +$5.73M 0.76% 46
2017
Q2 		$8.3M Sell
148,900
-18,200
-11% -$990K 0.55% 59
2017
Q1 		$9.09M Buy
167,100
+3,000
+2% +$165K 0.77% 42
2016
Q4 		$9.59M Buy
164,100
+123,000
+299% +$6.72M 0.45% 64
2016
Q3 		$2.22M Sell
41,100
-5,200
-11% -$334K 0.1% 124
2016
Q2 		$3.4M Sell
46,300
-75,600
-62% -$5.34M 0.17% 100
2016
Q1 		$7.79M Buy
121,900
+28,800
+31% +$1.82M 0.52% 60
2015
Q4 		$6.4M Sell
93,100
-30,000
-24% -$1.98M 0.33% 74
2015
Q3 		$7.29M Buy
123,100
+52,700
+75% +$3.34M 0.41% 69
2015
Q2 		$4.68M Sell
70,400
-88,000
-56% -$5.8M 0.29% 89
2015
Q1 		$10.2M Buy
158,400
+53,400
+51% +$3.34M 0.74% 41
2014
Q4 		$6.2M Sell
105,000
-26,200
-20% -$1.48M 0.37% 69
2014
Q3 		$6.71M Buy
131,200
+18,200
+16% +$909K 0.35% 74
2014
Q2 		$5.48M Buy
113,000
+63,500
+128% +$3.13M 0.29% 82
2014
Q1 		$2.57M Buy
49,500
+19,600
+66% +$1.04M 0.32% 41
2013
Q4 		$1.59M Sell
29,900
-79,500
-73% -$4.05M 0.08% 108
2013
Q3 		$5.06M Sell
109,400
-62,900
-37% -$2.76M 0.26% 84
2013
Q2 		$7.7M Buy
+172,300
New +$7.48M 0.38% 71

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CMT Asset Management's BMY Position: Q3 2017 in Review

CMT Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 13,000 shares — an estimated $759K sold.

CMT Asset Management first reported a position in BMY in Q4 2013 and held it in 7 quarters. The position peaked at $5.35M in Q4 2016. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • CMT Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
  • CMT Asset Management sold 13,000 Bristol-Myers Squibb shares in Q3 2017, an estimated $759K.
  • CMT Asset Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 7 quarters.
  • CMT Asset Management's Bristol-Myers Squibb position peaked at $5.35M in Q4 2016.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on CMT Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.